Community Development Venture Capital Alliance and New Orleans BioFund have co-invested in two bioscience startups, Informuta and Beken Bio, to boost operations in New Orleans. This funding marks Beken Bio’s relocation from San Diego to the New Orleans BioInnovation Center (NOBIC), highlighting the city’s growing appeal as a bioscience hub.
The co-investment, reported on March 3, 2026, involves seed funding for Informuta and pre-seed financing for Beken Bio. The move will support the development of a CLIA-certified laboratory at NOBIC, yet specific investment amounts remain undisclosed. Both startups will contribute to the growing demand for specialized lab space in the city’s BioDistrict.
Beken Bio, founded by Dr. Christopher Millan, will bring its operations to the BioInnovation Center, a key component of New Orleans’ strategy to expand its bioscience sector. With this relocation, Beken Bio aims to create jobs and enhance local commercialization capacities while Informuta, led by Dr. Kalen Hall and Leo Williams, focuses on rapid diagnostic results.
New Orleans’ BioDistrict, with NOBIC as a commercialization hub, is gaining traction as it attracts life science ventures. The strategic location offers potential benefits of increased real estate demand for wet-lab facilities. The economic activity is poised to stimulate private investment and additional infrastructure development.
While precise timelines for the laboratory development are currently unconfirmed, the move positions New Orleans as a significant player in the bioscience industry, potentially encouraging further relocations and investments. The involvement of mission-driven investors underscores the city’s economic development aspirations tied to commercial real estate growth.
LCMC Health to Invest $14M to Expand Services at Lakeside Hospital in Metairie Next Post:
about the author: CSB Staff
